{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:18:20Z","timestamp":1784546300475,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["2017A030313601"],"award-info":[{"award-number":["2017A030313601"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2502605"],"award-info":[{"award-number":["2022YFC2502605"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NSFC82170163"],"award-info":[{"award-number":["NSFC82170163"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970147"],"award-info":[{"award-number":["81970147"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jtct.2025.05.015","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T19:34:34Z","timestamp":1747942474000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cumulative Dose of PEG-asparaginase Is Associated with Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6371-3700","authenticated-orcid":false,"given":"Junjie","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zicong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieping","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawang","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuli","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingqing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifa","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongsheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jtct.2025.05.015_bib0001","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1182\/blood-2007-10-116582","volume":"111","author":"Goldstone","year":"2008","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.jtct.2025.05.015_bib0002","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood-2018-10-881961","article-title":"A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403","volume":"133","author":"Stock","year":"2019","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jtct.2025.05.015_bib0003","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1200\/JCO.2008.18.6916","article-title":"Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study","volume":"27","author":"Huguet","year":"2009","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.jtct.2025.05.015_bib0004","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.3324\/haematol.2023.284228","article-title":"Pediatric-inspired regimen for adolescent and adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia: a prospective study from China","volume":"109","author":"Gong","year":"2024","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.jtct.2025.05.015_bib0005","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1001\/jamaoncol.2017.5305","article-title":"Pediatric-inspired treatment regimens for adolescents and young adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: a review","volume":"4","author":"Siegel","year":"2018","journal-title":"JAMA Oncol"},{"issue":"10","key":"10.1016\/j.jtct.2025.05.015_bib0006","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/ajh.25229","article-title":"Treatment of young adults with Philadelphia-negative acute lymphoblastic leukemia and lymphoblastic lymphoma: Hyper-CVAD vs. pediatric-inspired regimens","volume":"93","author":"Siegel","year":"2018","journal-title":"Am J Hematol"},{"issue":"17","key":"10.1016\/j.jtct.2025.05.015_bib0009","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1200\/JCO.19.03024","article-title":"Impact of asparaginase discontinuation on outcome in childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group","volume":"38","author":"Gupta","year":"2020","journal-title":"J Clin Oncol"},{"issue":"17","key":"10.1016\/j.jtct.2025.05.015_bib0010","first-page":"2373_82","article-title":"Relapse risk following truncation of pegylated asparaginase in childhood acute lymphoblastic leukemia","volume":"137","author":"Gottschalk","year":"2021","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jtct.2025.05.015_bib0011","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/ijc.33529","article-title":"Adequate asparaginase is important to prevent central nervous system and testicular relapse of pediatric Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia","volume":"149","author":"Liu","year":"2021","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.jtct.2025.05.015_bib0012","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ctrv.2010.08.002","article-title":"Asparaginase in the management of adult acute lymphoblastic leukaemia: is it used appropriately?","volume":"37","author":"Patil","year":"2011","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jtct.2025.05.015_bib0013","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.19467","article-title":"STAT5 phosphorylation plus minimal residual disease defines a novel risk classification in adult B-cell acute lymphoblastic leukaemia","author":"Xu","year":"2024","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1016\/j.jtct.2025.05.015_bib0014","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1038\/s41409-022-01797-1","article-title":"Allogeneic hematopoietic stem cell transplantation overcome the poor prognosis of patients with IKZF1plus CD20\u2013a very high-risk subtype in B-cell acute lymphoblastic leukemia","volume":"57","author":"Tang","year":"2022","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2025.05.015_bib0015","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1200\/JCO.22.00767","article-title":"Busulfan plus cyclophosphamide versus total body irradiation plus cyclophosphamide for adults acute B lymphoblastic leukemia: an open-label, multicenter, phase III trial","volume":"41","author":"Zhang","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2025.05.015_bib0016","article-title":"PASS-ALL study of paediatric-inspired versus adult chemotherapy regimens on survival of high-risk Philadelphia-negative B-cell acute lymphoblastic leukaemia with allogeneic haematopoietic stem cell transplantation","author":"Wang","year":"2023","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.jtct.2025.05.015_bib0017","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1002\/hem3.82","article-title":"An integrated classification of tumor suppressor IKZF1 inactivation and oncogenic activation in Philadelphia chromosome-like acute lymphoblastic leukemia","volume":"8","author":"Huang","year":"2024","journal-title":"Hemasphere."},{"issue":"11","key":"10.1016\/j.jtct.2025.05.015_bib0018","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1038\/s41409-022-01796-2","article-title":"Effect of pediatric- versus adult-type chemotherapy regimens on outcomes of allogeneic hematopoietic stem cell transplants for adult T-cell acute lymphoblastic leukemia in first complete remission","volume":"57","author":"Qi","year":"2022","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2025.05.015_bib0019","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1200\/JCO.2000.18.3.547","article-title":"Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia","volume":"18","author":"Kantarjian","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2025.05.015_bib0008","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2024.285590","article-title":"Superior survival with allogeneic hematopoietic stem cell transplantation versus chemotherapy for high-risk adult acute lymphoblastic leukemia in a PDT-ALL-2016 pediatric-inspired cohort","author":"Chen","year":"2024","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.jtct.2025.05.015_bib0020","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1038\/leu.2012.122","article-title":"EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols","volume":"26","author":"Kalina","year":"2012","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.jtct.2025.05.015_bib0021","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13045-020-00859-5","article-title":"Haploidentical versus HLA-matched sibling transplantation for refractory acute leukemia undergoing sequential intensified conditioning followed by DLI: an analysis from two prospective data","volume":"13","author":"Yu","year":"2020","journal-title":"J Hematol Oncol"},{"issue":"7","key":"10.1016\/j.jtct.2025.05.015_bib0022","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1038\/s41375-020-01090-4","article-title":"A new pre-emptive TKIs strategy for preventing relapse based on BCR\/ABL monitoring for Ph+ALL undergoing allo-HCT: a prospective clinical cohort study","volume":"35","author":"Liu","year":"2021","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.jtct.2025.05.015_bib0023","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S1470-2045(20)30455-1","article-title":"Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial","volume":"21","author":"Xuan","year":"2020","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.jtct.2025.05.015_bib0024","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13045-021-01065-7","volume":"14","author":"Nagler","year":"2021","journal-title":"J Hematol Oncol"},{"issue":"1","key":"10.1016\/j.jtct.2025.05.015_bib0025","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1182\/bloodadvances.2021004916","article-title":"Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia","volume":"6","author":"Wieduwilt","year":"2022","journal-title":"Blood Adv"},{"issue":"14","key":"10.1016\/j.jtct.2025.05.015_bib0026","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1182\/blood.2020007311","article-title":"Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome-negative adult lymphoblastic leukemia","volume":"137","author":"Ribera","year":"2021","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.jtct.2025.05.015_bib0027","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1158\/1078-0432.CCR-15-2335","article-title":"Haploidentical versus matched-sibling transplant in adults with Philadelphia-negative high-risk acute lymphoblastic leukemia: a biologically phase III randomized study","volume":"22","author":"Wang","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.jtct.2025.05.015_bib0028","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1182\/blood-2014-03-563130","article-title":"Who is the best donor for a related HLA haplotype-mismatched transplant?","volume":"124","author":"Wang","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jtct.2025.05.015_bib0029","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13045-020-00859-5","article-title":"Haploidentical versus HLA-matched sibling transplantation for refractory acute leukemia undergoing sequential intensified conditioning followed by DLI: an analysis from two prospective data","volume":"13","author":"Yu","year":"2020","journal-title":"J Hematol Oncol"},{"issue":"3","key":"10.1016\/j.jtct.2025.05.015_bib0030","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/bjh.12639","article-title":"Minimal residual disease before and after transplantation for childhood acute lymphoblastic leukaemia: is there any room for intervention?","volume":"164","author":"Balduzzi","year":"2014","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.jtct.2025.05.015_bib0031","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/leu.2011.351","article-title":"Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMT","volume":"26","author":"Spyridonidis","year":"2012","journal-title":"Leukemia."},{"issue":"6","key":"10.1016\/j.jtct.2025.05.015_bib0032","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/ajh.26160","article-title":"Combination of CD19 and CD22 CAR-T cell therapy in relapsed B-cell acute lymphoblastic leukemia after allogeneic transplantation","volume":"96","author":"Liu","year":"2021","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.jtct.2025.05.015_bib0033","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s10875-011-9630-7","article-title":"Immune reconstitution following unmanipulated HLA-mismatched\/haploidentical transplantation compared with HLA-identical sibling transplantation","volume":"32","author":"Chang","year":"2012","journal-title":"J Clin Immunol"},{"issue":"18","key":"10.1016\/j.jtct.2025.05.015_bib0034","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1182\/blood-2014-11-608406","article-title":"Role of naive-derived T memory stem cells in T-cell reconstitution following allogeneic transplantation","volume":"125","author":"Roberto","year":"2015","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jtct.2025.05.015_bib0035","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/bmt.2014.266","article-title":"B-cell reconstitution recapitulates B-cell lymphopoiesis following haploidentical BM transplantation and post-transplant CY","volume":"50","author":"Roberto","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.05.015_bib0036","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ejca.2021.08.025","article-title":"How much asparaginase is needed for optimal outcome in childhood acute lymphoblastic leukaemia? A systematic review","volume":"157","author":"Brigitha","year":"2021","journal-title":"Eur J Cancer"},{"issue":"28","key":"10.1016\/j.jtct.2025.05.015_bib0037","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1200\/JCO.2005.11.411","article-title":"Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia","volume":"23","author":"Pession","year":"2005","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.jtct.2025.05.015_bib0038","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1182\/blood.2022017003","article-title":"NGS better discriminates true MRD positivity for the risk stratification of childhood ALL treated on an MRD-based protocol","volume":"141","author":"Svaton","year":"2023","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jtct.2025.05.015_bib0039","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41375-019-0544-3","article-title":"Haploidentical vs. unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia in first complete remission: on behalf of the ALWP of the EBMT","volume":"34","author":"Shem-Tov","year":"2020","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.jtct.2025.05.015_bib0040","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13045-019-0790-x","article-title":"Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT","volume":"12","author":"Pavl\u016f","year":"2019","journal-title":"J Hematol Oncol"},{"issue":"14","key":"10.1016\/j.jtct.2025.05.015_bib0041","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood-2018-10-881961","article-title":"A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403","volume":"133","author":"Stock","year":"2019","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jtct.2025.05.015_bib0042","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/leu.2017.265","article-title":"Results of NOPHO ALL2008 treatment for patients aged 1-45 years with acute lymphoblastic leukemia","volume":"32","author":"Toft","year":"2018","journal-title":"Leukemia"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725012011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725012011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T14:18:14Z","timestamp":1752589094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636725012011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":41,"alternative-id":["S2666636725012011"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2025.05.015","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cumulative Dose of PEG-asparaginase Is Associated with Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2025.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of The American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}